Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genocea Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Genocea Biosciences Secures USD16.09 Million in Venture Funding from Auriga Partners 12
Genocea Biosciences Raises US$0.4 Million In Venture Financing 13
Genocea Biosciences Raises US$30 Million In Series C Financing 14
Partnerships 16
Genocea Biosciences Enters into Research Agreement with Checkmate Pharma 16
Genocea Biosciences Enters into Agreement with US Oncology Research 17
Genocea Biosciences Enters into Agreement with Memorial Sloan Kettering Cancer Center 18
Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 19
Licensing Agreements 20
Genocea Biosciences Enters into Licensing Agreement with Oncovir 20
Equity Offering 21
Genocea Biosciences to Raise up to USD23.3 Million in Public Offering of Shares 21
Genocea Biosciences Raises USD53.4 Million in Public Offering of Shares 22
Genocea Biosciences Raises USD1.6 Million in Public Offering of Preferred Shares 24
Genocea Biosciences Raises USD50 Million in Public Offering of Shares 26
Genocea Biosciences Raises USD52 Million in Public Offering of Shares 28
Genocea Biosciences Raises USD2 Million in Private Placement of Shares 30
Genocea Biosciences Withdraws Public Offering of Shares 32
Genocea Biosciences Completes IPO For US$66 Million 33
Genocea Biosciences Inc – Key Competitors 35
Genocea Biosciences Inc – Key Employees 36
Genocea Biosciences Inc – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Financial Announcements 38
Aug 02, 2018: Genocea reports second quarter 2018 financial and operating results 38
May 10, 2018: Genocea Reports First Quarter 2018 Financial and Operating Results 39
Feb 15, 2018: Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results 40
Nov 02, 2017: Genocea Reports Third Quarter 2017 Financial Results 42
Aug 09, 2017: Genocea Biosciences Reports Second Quarter 2017 Financial Results 44
May 04, 2017: Genocea Reports First Quarter 2017 Financial Results 45
May 04, 2017: Genocea Biosciences Q1 net loss increases 46
Feb 16, 2017: Genocea Reports Fourth Quarter and Year-End 2016 Financial Results 47
Corporate Communications 49
Mar 12, 2018: Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing 49
Feb 12, 2018: Genocea Biosciences Names Ali Behbahani, M.D., As Board Director 50
Mar 06, 2017: Howard Mayer, M.D., of Shire, Joins Genocea Biosciences’ Board of Directors 51
Product News 52
09/25/2017: Genocea Announces Strategic Shift to Immuno-oncology and the Development of Neoantigen Cancer Vaccine GEN-009 52
04/18/2018: Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods 53
04/09/2018: Genocea to Present Data at Upcoming AACR Annual Meeting Further Highlighting ATLAS Platform Ability to Identify and Characterize Neoantigens for Cancer Vaccines 54
Product Approvals 55
Apr 30, 2018: Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genocea Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genocea Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genocea Biosciences Secures USD16.09 Million in Venture Funding from Auriga Partners 12
Genocea Biosciences Raises US$0.4 Million In Venture Financing 13
Genocea Biosciences Raises US$30 Million In Series C Financing 14
Genocea Biosciences Enters into Research Agreement with Checkmate Pharma 16
Genocea Biosciences Enters into Agreement with US Oncology Research 17
Genocea Biosciences Enters into Agreement with Memorial Sloan Kettering Cancer Center 18
Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 19
Genocea Biosciences Enters into Licensing Agreement with Oncovir 20
Genocea Biosciences to Raise up to USD23.3 Million in Public Offering of Shares 21
Genocea Biosciences Raises USD53.4 Million in Public Offering of Shares 22
Genocea Biosciences Raises USD1.6 Million in Public Offering of Preferred Shares 24
Genocea Biosciences Raises USD50 Million in Public Offering of Shares 26
Genocea Biosciences Raises USD52 Million in Public Offering of Shares 28
Genocea Biosciences Raises USD2 Million in Private Placement of Shares 30
Genocea Biosciences Withdraws Public Offering of Shares 32
Genocea Biosciences Completes IPO For US$66 Million 33
Genocea Biosciences Inc, Key Competitors 35
Genocea Biosciences Inc, Key Employees 36
List of Figures
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9